Skip to content
★ Sign in to follow
MW

Michael W. Nall

CEO
Biocept Inc
Total declarations
12
Company
1
▲ Purchases (2 ops.)
€50k
▼ Sales (0 ops.)
—

Latest filing published 02 Jun 2017 for BIOCEPT INC.

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Michael W. Nall: trading record in brief

This profile gathers the share dealings of Michael W. Nall in Biocept Inc. Between 13 February 2015 and 31 May 2017, the trades on record add up to 12 filings.

The open-market record is one-sided, with 2 purchases worth €50k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants and 1 option exercise.

Most recently, on 2 June 2017, the filings show a share grant in Biocept Inc. The last purchase on record was published on 21 October 2016, which is 3,670 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Michael W. Nall

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total
  • ◆
    CEO & PresidentExecutivesBiocept Inc
    0SEC
    50,000 shares0Common StockSEC:0001209191-17-037181:0
  • ●
    CEO & PresidentExecutivesBiocept Inc
    0SEC
    4,450 shares0Common StockSEC:0001209191-16-146646:4
  • ●
    CEO & PresidentExecutivesBiocept Inc
    0SEC
    4,450 shares0Common StockSEC:0001209191-16-146646:5
  • ●
    CEO & PresidentExecutivesBiocept Inc
    0SEC
    4,000 shares0Common StockSEC:0001209191-16-146646:0
  • ●
    CEO & PresidentExecutivesBiocept Inc
    0SEC
    4,000 shares0Common StockSEC:0001209191-16-146646:1
  • ●
    CEO & PresidentExecutivesBiocept Inc
    0SEC
    4,762 shares0Common StockSEC:0001209191-16-146646:2
  • ●
    CEO & PresidentExecutivesBiocept Inc
    0SEC
    4,762 shares0Common StockSEC:0001209191-16-146646:3
  • ▲
    CEO & PresidentExecutivesBiocept Inc
    39,999 USD48SEC
    36,363 shares@ US$1.10100.0% of flowCommon StockSEC:0001209191-16-146646:6
    Canonical exit: 17 Jan 2017 (T+90)
  • ◆
    CEO & PresidentExecutivesBiocept Inc
    0SEC
    75,000 shares0Common StockSEC:0001209191-16-132036:0
  • ◆
    CEO & PresidentExecutivesBiocept Inc
    0SEC
    13,348 shares0Common StockSEC:0001209191-16-103902:0
  • ◇
    CEO & PresidentExecutivesBiocept Inc
    0SEC
    14,286 sharesCommon StockSEC:0001209191-15-067845:0

11 of 11 declarations